Molecular and cellular effects of a novel hydroxamate-based HDAC inhibitor - belinostat - in glioblastoma cell lines: a preliminary report
published in: Investigational New Drugs
date of publication: 2016-07-29
language: English
main subject: glioblastoma
Cites articles 40
Date
Title
Article - wd:Q37222794